Cargando…

Stratifying the stratifiers of triple negative breast cancer

Detalles Bibliográficos
Autores principales:	Wang, Dong-Yu, Jiang, Zhe, Zacksenhaus, Eldad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996905/ https://www.ncbi.nlm.nih.gov/pubmed/32064036 http://dx.doi.org/10.18632/oncotarget.27455

Ejemplares similares

Stratifying triple-negative breast cancer: which definition(s) to use?
por: Adamo, Barbara, et al.
Publicado: (2011)

Molecular stratification within triple-negative breast cancer subtypes
por: Wang, Dong-Yu, et al.
Publicado: (2019)

Stratifying triple-negative breast cancer prognosis using 18F-FDG-PET/CT imaging
por: Yue, Yong, et al.
Publicado: (2015)

The vulnerability of RB loss in breast cancer: Targeting a void in cell cycle control
por: Knudsen, Erik S., et al.
Publicado: (2018)

CDK4/6 inhibitors and the pRB-E2F1 axis suppress PVR and PD-L1 expression in triple-negative breast cancer
por: Shrestha, Mariusz, et al.
Publicado: (2023)

Risk-stratified colorectal cancer screening for optimal use of colonoscopy resources
por: Yang, Dong-Hoon
Publicado: (2021)

Stratifying primary Sjögren’s syndrome: killers in the balance?
por: Bowman, Simon J., et al.
Publicado: (2015)

Stratified medicine in rheumatoid arthritis—the MATURA programme
por: Barton, Anne, et al.
Publicado: (2017)

A subgroup of microRNAs defines PTEN-deficient, triple-negative breast cancer patients with poorest prognosis and alterations in RB1, MYC, and Wnt signaling
por: Wang, Dong-Yu, et al.
Publicado: (2019)

Inhibition of eEF2K synergizes with glutaminase inhibitors or 4EBP1 depletion to suppress growth of triple-negative breast cancer cells
por: Ju, YoungJun, et al.
Publicado: (2021)

A Predictor of Pathological Complete Response to Neoadjuvant Chemotherapy Stratifies Triple Negative Breast Cancer Patients with High Risk of Recurrence
por: Fournier, Marcia V., et al.
Publicado: (2019)

Progression to Metastasis of Solid Cancer
por: Zacksenhaus, Eldad, et al.
Publicado: (2021)

Sex Stratified Treatment of Neurological Disorders: Challenges and Perspectives
por: Nalvarte, Ivan
Publicado: (2020)

Stratifying Bronchiectasis: Getting to within a Zone’s Throw
por: Chotirmall, Sanjay H.
Publicado: (2019)

Identification of CDC25 as a Common Therapeutic Target for Triple-Negative Breast Cancer
por: Liu, Jeff C., et al.
Publicado: (2018)

Stratified polyhedra
por: Stone, David A
Publicado: (1972)

Stratified flows
por: Yih, Chia-Shun
Publicado: (1980)

“If Not Us, Then Who? If Not Now, Then When?” - The Need for Resource Stratified Guidelines
por: Bhatnagar, Sushma
Publicado: (2016)

Triple-Negative Breast Cancer
por: Chu, Quyen D., et al.
Publicado: (2012)

The current status of risk-stratified breast screening
por: Clift, Ash Kieran, et al.
Publicado: (2021)

How to risk-stratify elective surgery during the COVID-19 pandemic?
por: Stahel, Philip F.
Publicado: (2020)

Noninvasive markers: a double-edged sword that stratifies nonalcoholic steatohepatitis
por: Chung, Goh Eun, et al.
Publicado: (2013)

Environmental stratified flows
por: Armenio, Vincenzo, et al.
Publicado: (2006)

Stratified Morse theory
por: Goresky, Mark, et al.
Publicado: (1988)

Stratifying endomorphism algebras
por: Scott, Leonard, et al.
Publicado: (1996)

High tumor budding stratifies breast cancer with metastatic properties
por: Salhia, Bodour, et al.
Publicado: (2015)

Quantifying Tip60 (Kat5) stratifies breast cancer
por: McGuire, A., et al.
Publicado: (2019)

Genetic Testing to Guide Risk-Stratified Screens for Breast Cancer
por: Willoughby, Ava, et al.
Publicado: (2019)

Risk‐based breast cancer follow‐up stratified by age
por: Witteveen, Annemieke, et al.
Publicado: (2018)

Is risk-stratified breast cancer screening economically efficient in Germany?
por: Arnold, Matthias, et al.
Publicado: (2019)

The cost-effectiveness of risk-stratified breast cancer screening in the UK
por: Hill, Harry, et al.
Publicado: (2023)

RB1 Status in Triple Negative Breast Cancer Cells Dictates Response to Radiation Treatment and Selective Therapeutic Drugs
por: Robinson, Tyler J. W., et al.
Publicado: (2013)

Activation of retinoblastoma protein in mammary gland leads to ductal growth suppression, precocious differentiation, and adenocarcinoma
por: Jiang, Zhe, et al.
Publicado: (2002)

Quantitative proteome profiling stratifies fibroepithelial lesions of the breast
por: Kumar, Aviral, et al.
Publicado: (2021)

High-throughput screen identifies disulfiram as a potential therapeutic for triple-negative breast cancer cells: Interaction with IQ motif-containing factors
por: Robinson, Tyler JW, et al.
Publicado: (2013)

Immunoprofile from tissue microarrays to stratify familial breast cancer patients
por: Schirosi, Laura, et al.
Publicado: (2015)

Quantifying Argonaute 2 (Ago2) expression to stratify breast cancer
por: Casey, M.C., et al.
Publicado: (2019)

A new score to stratify the risk in tricuspid regurgitation: the icing on the cake
por: Donal, Erwan, et al.
Publicado: (2022)

Turing Patterning in Stratified Domains
por: Krause, Andrew L., et al.
Publicado: (2020)

Stratified Medicine and Reimbursement Issues
por: Fugel, Hans-Joerg, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_lo2l3bj6v23eo666pfdmmjuuvc